Study to Evaluate the Safety of CG-P5 Peptide Eye Drops in Patients Diagnosed With Age-related Wet Macular Degeneration
Condition(s):Age-related Wet Macular DegenerationLast Updated:November 15, 2023Not yet recruiting
Hide Studies Not Open or Pending
Condition(s):Age-related Wet Macular DegenerationLast Updated:November 15, 2023Not yet recruiting
Condition(s):Exudative Macular DegenerationLast Updated:July 26, 2018Completed
Condition(s):Exudative Macular Degeneration; Diabetic Macular EdemaLast Updated:December 17, 2014Completed
Condition(s):Wet Macular DegenerationLast Updated:December 29, 2023Recruiting
Condition(s):Wet Macular DegenerationLast Updated:January 6, 2022Completed
Condition(s):Wet Macular DegenerationLast Updated:September 14, 2015Completed
Condition(s):Wet Macular DegenerationLast Updated:June 6, 2022Terminated
Condition(s):Wet Macular Degeneration; Wet Age-related Macular DegenerationLast Updated:October 6, 2020Completed
Condition(s):Wet Macular DegenerationLast Updated:February 12, 2014Completed
Condition(s):Exudative Age Related Macular DegenerationLast Updated:October 22, 2020Completed
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.